Literature DB >> 23737569

Use of the AngioJet percutaneous thrombectomy system for the treatment of acute Budd-Chiari syndrome.

Adam Doyle1, Amanda Nicoll, Richard Dowling.   

Abstract

A 31-year-old woman presented to our emergency department with an acute liver injury secondary to acute Budd-Chiari (BC) syndrome from hepatic vein thrombosis. After a thorough discussion of the risks involved, we proceeded to treatment with a novel approach, performing a mechanical hepatic vein thrombectomy with the AngioJet percutaneous thrombectomy system. Restoration of hepatic vein flow was confirmed with on-table Doppler ultrasound. There were no complications following the procedure. The patient was initiated on anticoagulation, and showed progressive clinical and laboratory improvement. She was discharged home on day 20 with normal liver function and biochemistry. This is the first reported case of successful mechanical thrombectomy in acute BC syndrome without the addition of angioplasty or chemical thrombolysis.

Entities:  

Mesh:

Year:  2013        PMID: 23737569      PMCID: PMC3702805          DOI: 10.1136/bcr-2013-008632

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

Authors:  C E Eapen; D Velissaris; M Heydtmann; B Gunson; S Olliff; E Elias
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

2.  Vascular disorders of the liver.

Authors:  Laurie D DeLeve; Dominique-Charles Valla; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

3.  Budd-Chiari syndrome: intractable ascites managed by a trans-hepatic portacaval shunt.

Authors:  A Nicoll; G Fitt; P Angus; R Sewell; O Hennessy
Journal:  Australas Radiol       Date:  1997-05

4.  Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome.

Authors:  Aurélie Plessier; Annie Sibert; Yann Consigny; Antoine Hakime; Magaly Zappa; Marie-Hélène Denninger; Bertrand Condat; Olivier Farges; Carine Chagneau; Victor de Ledinghen; Claire Francoz; Alain Sauvanet; Valérie Vilgrain; Jacques Belghiti; François Durand; Dominique Valla
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

5.  Bleeding in patients with Budd-Chiari syndrome.

Authors:  Pierre-Emmanuel Rautou; Ludivine Douarin; Marie-Hélène Denninger; Sylvie Escolano; Didier Lebrec; Richard Moreau; Michel Vidaud; Raphaël Itzykson; Rami Moucari; Annie Bezeaud; Dominique Valla; Aurélie Plessier
Journal:  J Hepatol       Date:  2010-08-20       Impact factor: 25.083

6.  Good long-term outcome of Budd-Chiari syndrome with a step-wise management.

Authors:  Susana Seijo; Aurelie Plessier; Jildou Hoekstra; Alessandra Dell'era; Dalvinder Mandair; Kinan Rifai; Jonel Trebicka; Isabelle Morard; Luc Lasser; Juan G Abraldes; Sarwa Darwish Murad; Jörg Heller; Antoine Hadengue; Massimo Primignani; Elwyn Elias; Harry L A Janssen; Dominique C Valla; Juan-Carlos Garcia-Pagan
Journal:  Hepatology       Date:  2013-05       Impact factor: 17.425

7.  TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.

Authors:  Juan Carlos Garcia-Pagán; Mathis Heydtmann; Sebastian Raffa; Aurélie Plessier; Sarwa Murad; Federica Fabris; Giovanni Vizzini; Juan Gonzales Abraldes; Simon Olliff; Antonio Nicolini; Angelo Luca; Massimo Primignani; Harry L A Janssen; Dominique Valla; Elwyn Elias; Jaume Bosch
Journal:  Gastroenterology       Date:  2008-05-21       Impact factor: 22.682

8.  Catheter-directed thrombolysis and thrombectomy for the Budd-Chiari syndrome in paroxysmal nocturnal hemoglobinuria in three patients.

Authors:  George P Kuo; Robert A Brodsky; Hyun S Kim
Journal:  J Vasc Interv Radiol       Date:  2006-02       Impact factor: 3.464

9.  Use of the Arrow percutaneous thrombectomy device and transjugular liver biopsy cannula for mechanical thrombectomy of the inferior vena cava in a patient with Budd-Chiari syndrome.

Authors:  Ziv J Haskal
Journal:  J Vasc Interv Radiol       Date:  2007-07       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.